ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 771 filers reported holding ASTRAZENECA PLC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $216,797 | -7.2% | 2,780 | -19.8% | 0.02% | -13.6% |
Q4 2023 | $233,502 | +3.4% | 3,467 | +9.9% | 0.02% | -12.0% |
Q2 2023 | $225,803 | -1.2% | 3,155 | -4.2% | 0.02% | +4.2% |
Q1 2023 | $228,637 | -55.4% | 3,294 | -57.6% | 0.02% | -54.7% |
Q2 2022 | $513,000 | +1.2% | 7,768 | +1.7% | 0.05% | +15.2% |
Q1 2022 | $507,000 | +23.4% | 7,636 | +8.3% | 0.05% | +48.4% |
Q4 2021 | $411,000 | -7.4% | 7,051 | -4.7% | 0.03% | -13.9% |
Q3 2021 | $444,000 | +14.7% | 7,401 | +14.6% | 0.04% | +12.5% |
Q2 2021 | $387,000 | +20.6% | 6,460 | 0.0% | 0.03% | +10.3% |
Q1 2021 | $321,000 | -39.4% | 6,460 | -39.1% | 0.03% | -44.2% |
Q4 2020 | $530,000 | -51.0% | 10,605 | -46.3% | 0.05% | -56.7% |
Q3 2020 | $1,081,000 | +236.8% | 19,734 | +225.2% | 0.12% | +215.8% |
Q2 2020 | $321,000 | +11.8% | 6,069 | -5.5% | 0.04% | -5.0% |
Q1 2020 | $287,000 | -65.9% | 6,422 | -71.8% | 0.04% | -9.1% |
Q4 2019 | $842,000 | +155.9% | 22,760 | +207.9% | 0.04% | -2.2% |
Q3 2019 | $329,000 | – | 7,391 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |